Nathalie Rioux-Leclercq

Papers

Total Citations

H-Index

About

Nathalie Rioux-Leclercq is a leading French pathologist and oncologist whose research centers on urological cancers, particularly kidney cancer. She has made seminal contributions to the understanding of renal cell carcinoma (RCC) through her work on tumor classification, prognostic biomarkers, and the molecular mechanisms driving disease progression. Her research has been instrumental in refining histopathological grading systems and identifying genetic signatures that guide personalized treatment strategies. With over 10,000 citations, her work has profoundly shaped clinical guidelines and therapeutic approaches. Notably, she chaired the French AFU Cancer Committee’s 2024–2026 update on kidney cancer management, a comprehensive review that synthesizes the latest evidence on diagnosis, surgery, and medical therapy. This guideline, already cited 10 times, underscores her role as a key opinion leader in urological oncology. Rioux-Leclercq’s dedication to bridging pathology and clinical practice has earned her international recognition, making her a vital resource for researchers and clinicians seeking to improve outcomes for patients with kidney cancer.